TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
JBIO

Jade Biosciences, Inc.

Healthcare · Biotechnology

14.40$ -2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Jade Biosciences, Inc. (JBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 472 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JBIO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
141 127 107 112 91 80 78 224 202 350 319 472
138 124 103 111 91 80 77 223 201 336 319 471
32 23 9.1 31 31 34 44 221 50 88 55 107
135 122 99 104 89 79 76 221 199 336 311 461
15 18 16 17 10 3.9 2.5 22 23 17 23 32
15 18 16 17 10 3.8 2.4 22 22 17 22 32
0.5 0.4 0.4 0.5 0.5 0.4 0.3 – – – – –
3.5 2.4 3.3 4.2 0.9 0.2 0.1 7.6 1.4 2.2 4.0 6.6
– – – – 97 – – – – – – –
126 109 91 94 80 76 75 202 179 333 296 440
-143 -163 -187 -211 -228 -233 -236 -117 -142 -174 -215 -271
0.8 0.8 0.8 0.8 3.2 0.8 0.8 28 40 49 58 61

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?